CY1121568T1 - Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου - Google Patents

Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου

Info

Publication number
CY1121568T1
CY1121568T1 CY20191100409T CY191100409T CY1121568T1 CY 1121568 T1 CY1121568 T1 CY 1121568T1 CY 20191100409 T CY20191100409 T CY 20191100409T CY 191100409 T CY191100409 T CY 191100409T CY 1121568 T1 CY1121568 T1 CY 1121568T1
Authority
CY
Cyprus
Prior art keywords
local
provision
nervous
exclusion
analgesia
Prior art date
Application number
CY20191100409T
Other languages
English (en)
Inventor
Michael Myers
Philip Wallace Reginald
Original Assignee
Innocoll Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IE2007/0220A external-priority patent/IE85880B1/en
Priority claimed from US11/692,337 external-priority patent/US20080241243A1/en
Application filed by Innocoll Pharmaceuticals Limited filed Critical Innocoll Pharmaceuticals Limited
Publication of CY1121568T1 publication Critical patent/CY1121568T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η εφεύρεση σχετίζεται με μια διάταξη παροχής φαρμάκου για την παροχή τοπικής αναλγησίας, τοπικής αναισθησίας ή νευρικού αποκλεισμού σε ένα σημείο σ' ένα άνθρωπο ή ζώο που την χρειάζεται, όπου η διάταξη περιλαμβάνει μια ινώδη μήτρα κολλαγόνου• και τουλάχιστον μια φαρμακευτική ουσία, που επιλέγεται από την ομάδα που αποτελείται από τα αμινο-αμιδικά αναισθητικά, τα αμινο-εστερικά αναισθητικά και τα μείγματα αυτών, όπου η τουλάχιστον μία φαρμακευτική ουσία είναι ουσιαστικά ομοιογενώς διασκορπισμένη στη μήτρα κολλαγόνου και η τουλάχιστον μία φαρμακευτική ουσία υπάρχει σε επαρκή ποσότητα για να παράσχει διάρκεια τοπικής αναλγησίας, τοπικής αναισθησίας ή νευρικού αποκλεισμού τουλάχιστον μιας ημέρας περίπου μετά την χορήγηση.
CY20191100409T 2007-03-28 2019-04-12 Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου CY1121568T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IE2007/0220A IE85880B1 (en) 2007-03-28 A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
US11/692,337 US20080241243A1 (en) 2007-03-28 2007-03-28 Drug delivery device for providing local analgesia, local anesthesia or nerve blockade
PCT/IE2008/000035 WO2008117268A2 (en) 2007-03-28 2008-03-28 A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
EP08719893.3A EP2139457B1 (en) 2007-03-28 2008-03-28 A drug delivery device for providing local analgesia, local anesthesia or nerve blockade

Publications (1)

Publication Number Publication Date
CY1121568T1 true CY1121568T1 (el) 2020-05-29

Family

ID=39540798

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20161100677T CY1117814T1 (el) 2007-03-28 2016-07-14 Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου
CY20191100409T CY1121568T1 (el) 2007-03-28 2019-04-12 Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20161100677T CY1117814T1 (el) 2007-03-28 2016-07-14 Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου

Country Status (15)

Country Link
EP (2) EP3085363B1 (el)
JP (1) JP5372905B2 (el)
CY (2) CY1117814T1 (el)
DE (1) DE202008018583U1 (el)
DK (2) DK3085363T3 (el)
ES (2) ES2718542T3 (el)
HR (2) HRP20160743T1 (el)
HU (2) HUE043185T2 (el)
IE (1) IES20080229A2 (el)
LT (1) LT3085363T (el)
PL (2) PL2139457T3 (el)
PT (2) PT2139457T (el)
SI (2) SI2139457T1 (el)
TR (1) TR201905174T4 (el)
WO (1) WO2008117268A2 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE47826E1 (en) 2007-03-28 2020-01-28 Innocoll Pharmaceuticals Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
EP2352531A2 (en) * 2008-11-06 2011-08-10 Innocoll Technologies Limited Drug delivery implants and processes for their preparation
US8858983B2 (en) 2009-04-30 2014-10-14 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
US8911427B2 (en) 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
EP3613413A1 (en) * 2011-12-05 2020-02-26 Incept, LLC Medical organogel processes and compositions
PL2802624T3 (pl) 2012-01-09 2018-02-28 Innocoll Pharmaceuticals Limited Zmodyfikowany kolagen
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
JP6363115B2 (ja) * 2013-02-28 2018-07-25 ミラ ファーマ コーポレイション 注射可能局所麻酔半固体製剤およびその組成物
RU2561301C1 (ru) * 2014-10-06 2015-08-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Омский государственный аграрный университет имени П.А. Столыпина" Способ трансфеморальной блокады нервов мочевого пузыря у мелких животных
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
AU2022213016A1 (en) * 2021-02-01 2023-08-24 Massey University Post-operative pain management
WO2022219179A1 (en) * 2021-04-15 2022-10-20 Innocoll Pharmaceuticals Limited Drug-release implant for soft tissue surgery
WO2023006922A2 (en) * 2021-07-28 2023-02-02 Innocoll Pharmaceuticals Limited Bupivacaine-collagen drug delivery implant and methods of making and using thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4125400C2 (de) * 1991-07-31 2000-08-17 Edwin Klaus Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen
JPH08143449A (ja) * 1994-11-17 1996-06-04 Lederle Japan Ltd 徐放性局所麻酔用注射剤
US7119062B1 (en) * 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US20080124400A1 (en) * 2004-06-24 2008-05-29 Angiotech International Ag Microparticles With High Loadings Of A Bioactive Agent
LT2767292T (lt) * 2004-09-17 2016-12-12 Durect Corporation Palaikomosios vietinės anestezijos mišinys su saib
UA88321C2 (ru) * 2004-09-30 2009-10-12 Ковалон Текнолоджиз Инк. Неадгезивные эластичные желатиновые матрицы

Also Published As

Publication number Publication date
PL3085363T3 (pl) 2019-08-30
PT2139457T (pt) 2016-07-26
PL2139457T3 (pl) 2016-11-30
DK3085363T3 (en) 2019-04-29
EP2139457B1 (en) 2016-05-04
IES20080229A2 (en) 2008-12-24
WO2008117268A3 (en) 2009-03-26
HUE043185T2 (hu) 2019-08-28
HRP20160743T1 (hr) 2016-09-23
WO2008117268A2 (en) 2008-10-02
JP2010522738A (ja) 2010-07-08
HRP20190699T1 (hr) 2019-07-12
SI2139457T1 (sl) 2016-09-30
SI3085363T1 (sl) 2019-07-31
LT3085363T (lt) 2019-06-25
EP2139457A2 (en) 2010-01-06
DE202008018583U1 (de) 2016-03-14
CY1117814T1 (el) 2017-05-17
ES2582368T3 (es) 2016-09-12
ES2718542T3 (es) 2019-07-02
HUE027803T2 (en) 2016-10-28
PT3085363T (pt) 2019-05-16
TR201905174T4 (tr) 2019-05-21
JP5372905B2 (ja) 2013-12-18
EP3085363A1 (en) 2016-10-26
EP3085363B1 (en) 2019-03-20
DK2139457T3 (en) 2016-07-25

Similar Documents

Publication Publication Date Title
CY1121568T1 (el) Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου
Gurney Pharmacological options for intra‐operative and early postoperative analgesia: an update
Ducharme Acute pain and pain control: state of the art
ES2393211T3 (es) Uso de 2-aminotetralinas sustituidas para la fabricación de un medicamento para la prevención, alivio y/o tratamiento de diversos tipos de dolor
Santos et al. Effects of intraarticular ropivacaine and morphine on lipopolysaccharide‐induced synovitis in horses
Nadeson et al. Antinociceptive role of 5‐HT1A receptors in rat spinal cord
CY1119597T1 (el) Συνθεσεις και μεθοδοι για υπερκεραση αντοχης σε τραμαδολη
Ahn et al. Analgesic efficacy of preemptive pregabalin administration in arthroscopic shoulder surgery: a randomized controlled trial
CY1113575T1 (el) Χρηση συνθεσεων οπιοειδων σε συσκευες χορηγησης δραστικης ουσιας χωρις βελονα
Ghoreishi-Haack et al. NYX-2925 is a novel N-Methyl-d-Aspartate receptor modulator that induces rapid and long-lasting analgesia in rat models of neuropathic pain
Lorenzutti et al. Evaluation of the antiemetic efficacy of maropitant in dogs medicated with morphine and acepromazine
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
Tornero et al. Analgesia multimodal y anestesia regional
ES2313254T3 (es) Benzoxazinas para la prevencion o el tratamiento de la hiperalgesia inducida por los compuestos morfinicos.
Samcam et al. Acute pain management in the emergency department
Shadangi et al. A prospective, randomized, double-blind, comparative study of the efficacy of intravenous ondansetron and palonosetron for prevention of postoperative nausea and vomiting
Sala-Blanch et al. The PECS II block as a major analgesic component for clavicle operations: a description of 7 case reports
Cicirelli et al. Fentanyl patch versus tramadol for the control of postoperative pain in canine ovariectomy and mastectomy
Jendi et al. Comparison of local anaesthetic efficacy of tramadol versus lignocaine for extraction of tooth under supraperiosteal infiltration
Carnaval et al. Effects of opioids on local anesthesia in the rat: a codeine and tramadol study
Tuncer et al. Effect of gabapentin on postoperative pain: a randomized, placebo-controlled clinical study
Zhang et al. Microinjection of different doses of norepinephrine into the caudate putamen produces opposing effects in rats
Luca et al. In-vivo safety and efficacy evaluation of a novel polymeric based lidocaine formulation for topical analgesia
Curros‐Criado et al. Antinociceptive effects of NCX‐701 (nitro‐paracetamol) in neuropathic rats: enhancement of antinociception by co‐administration with gabapentin
George et al. Analgesic effect of dermatological patch in orthodontic Patients.